• Global hemp retail sales totaled $3.7 billion in 2018, on track to reach $5.7 billion by 2020
• 2018 Farm Bill legalizing hemp, CBD-based products, now allows farmers to plant industrial hemp nationwide
• Cultivation of hemp at Scio, Oregon, project site to begin in early 2019 for an extended growing season
• MCOA’s wholly owned subsidiary, hempSMART, brings high quality, branded CBD-based products to consumers through an affiliate marketing program

Market opportunities for the hemp-based cannabidiol (“CBD”) product industry in the U.S. are many and growing now that hemp is legally protected following passage of the 2018 Farm Bill in December. Innovative hemp and cannabis corporation Marijuana Company of America Inc. (OTCQB: MCOA) is well positioned to take advantage of this shift in the legal landscape, with a variety of portfolio companies operating within the cannabis and hemp industries (http://ibn.fm/od81k).

MCOA’s wholly owned hempSMART subsidiary offers a line of industrial hemp-derived CBD products, which contain no THC, the psychoactive compound in cannabis. The company’s hempSMART associate marketing program (http://ibn.fm/RISrJ) provides opportunities for others to become part of the hempSMART family through a unique distribution model. As a company primarily focused on industrial hemp-CBD products, MCOA targets a growing wellness industry with its branded CBD line of hemp-derived products (http://ibn.fm/MwbuU).

The U.S. hemp crop tripled in 2018, with acreage rising rapidly in the 24 states actively growing last year, according to advocacy group Vote Hemp, and that figure is expected to grow now that the Farm Bill has opened the door to nationwide hemp production. Total American hemp acreage was at 78,176 acres last year, up from 25,713 in 2017, to an article in Hemp Industry Daily (http://ibn.fm/j3x5s).

Hemp production is destined to grow in Oregon as well after MCOA announced on January 10 that clone production at the company’s Scio, Oregon, high-yielding CBD hemp project is underway. MCOA and joint venture partner Global Hemp Group Inc. (OTC: GBHPF) (CSE: GHG) (FRANKFURT: GHG) are preparing to begin planting as early as possible in 2019, which will have a positive effect on the length of the growing season (http://ibn.fm/oTuZp).

The company will cultivate at least three strains of hemp, characterized by high CBD content, ultra-low levels of THC and substantial biomass yields. The selected strains have superior pest resistance and a shorter flowering period, enabling earlier harvest (http://ibn.fm/B9CMm). The hardiest phenotypes will create the mother plants that will be in the heart of the cloning process. MCOA started the cloning process in November 2018, soon after the completion of the annual harvest and drying operation. As a result of the cloning operation, MCOA expects to have approximately 40,000 plants that will be needed for the lower 35 acres of the farm.

Covered Bridge Acres (“CBA”), the project operating company, has already received Oregon Department of Agriculture registration to cultivate hemp in 2019. In addition, CBA has a permit to produce and handle agricultural hemp seed, which means that a seed breeding program can be established. CBD-rich hemp seed is another huge market opportunity as hemp growers seek certified seeds that have been tested against germination and uniformity benchmarks, including low levels of THC, according to an article in Hemp Industry Daily (http://ibn.fm/9mAWR).

According to a first-of-its-kind report from data analytics firm New Frontier Data, ‘The Global State of Hemp: 2019 Industry Outlook’, global hemp retail sales totaled $3.7 billion in 2018 and are on track to grow to $5.7 billion by 2020, as an article published by The Motley Fool reports (http://ibn.fm/oVz3P). New Frontier Data’s report estimates that U.S. hemp sales will have jumped to $2.6 billion by 2022, representing a compound annual growth rate of 27 percent. Of this $2.6 billion in hemp sales, half ($1.3 billion) are expected to stem from hemp-derived CBD products.

MCOA continues to work to create value for its shareholders with diverse initiatives, including strategically investing in synergistic companies to develop a varied portfolio of subsidiaries and joint ventures. MCOA envisions a future in which it will be a model for entrepreneurs and businesses that share its common goals and philosophies. This includes creating an environment for businesses to improve quality of life for their customers.

For more information, visit the company’s website at www.MarijuanaCompanyofAmerica.com

• The Green Organic Dutchman is building on a series of agreements to scale up its cannabis production operations in Canada, Jamaica, Europe and Latin America
• The Company’s first crop goes on sale soon to an exclusive loyalty group of patients and investors
• The Dutchman’s production strategy envisions 80,000 kilograms of cultivation by the end of this year en route to 219,000-kilogram buildout by 2021
• The company’s focus is on a premium organic brand built to high standards of environmental friendliness

Canada’s prime mover efforts to legalize the use of cannabis nationwide, not only as a medicinal substance but also as a wellness-enhancing consumable and a recreational drug, has made it a fertile field for entrepreneurial innovation and a friend to innovative business operations such as The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) – an Ontario-based producer of 100 percent-certified organic cannabis with an expanding footprint.

The Green Organic Dutchman, also known simply by its ticker, ‘TGOD’, was described by cannabis news outlet The Motley Fool last year as one of Canada’s top seven marijuana growers, thanks largely to the company’s plans to produce some 200,000 kilograms (about 440,000 pounds) in annual yield when it reaches full capacity. While construction of its almost 1.7 million square feet of cultivation facilities across Ontario, Quebec, and Jamaica (http://ibn.fm/YjquT) continues, TGOD has been cultivating in Ontario on a small scale since 2016 and began delivering its first commercial crop to an exclusive loyalty pool of patients and investors this month (http://ibn.fm/FDD5c).

The first phase of construction at the Ontario site is expected to be complete during the second quarter of this year, establishing an enclosed facility capable of producing 2,000 kilograms of cannabis. The company will then continue, with a hybrid facility capable of 14,500 kilograms expected to be completed in Q2 as well. At the Quebec site, which will reach 185,000 kilograms of organic cannabis at buildout, the first cultivation is expected in the fourth quarter of this year.

When the company’s purpose-built hybrid greenhouses are complete, they will stand as a testament to the Dutchman’s commitment to minimizing its environmental impact. They are expected to be among the largest LEED (Leadership in Energy and Environmental Design) system-certified facilities in the world and will also be completed to European Union good manufacturing practice (“eGMP”) standards in anticipation of expansion into that market.

TGOD has chosen to reject irradiation of its product — a process that can extend the shelf life of foods, but also one that adversely affects the terpenes in cannabis that are responsible for scent and flavor. Likewise, the company uses carbon dioxide rather than solvents or additives to extract oils from cannabis with minimal environmental impact.

Earlier this month, TGOD announced an agreement to supply cannabis to the Ontario Cannabis Retail Corporation (“OCRC”), the latest in a series of ventures that include product distribution in Denmark, Jamaica, Mexico and Poland. The OCRC is the only legal online store for recreational cannabis in Ontario and will also become the provincial wholesaler of cannabis for private retail stores once the regulatory framework is in place this spring.

A run-rate timeline published by the company shows that it expects to go from producing over 20,000 kilograms of cannabis by the third quarter of this year to more than 80,000 kilograms by the fourth quarter, and then to 219,000 kilograms by the third quarter of 2021 (http://ibn.fm/QTjgn).

TGOD’s agreement with global power management company Eaton Corp. is also enabling it to increase its revenue margins, because Eaton is providing TGOD with some of the lowest electricity input costs in the business as part of a research and optimization project that Eaton is using to advance its profile in cannabis growing power management and lighting on a global scale. The agreement is one more example of the Dutchman’s foresight in executing productive partnerships to establish a low-cost, high-quality product that will benefit the consumer.

For more information, visit the company’s website at www.TGOD.ca

• Tinley Beverage Company is the first public company to market with cannabis-infused beverages that authentically mirror popular liquors, without the alcohol content
• With a sole focus on THC-infused beverages and operations in the U.S.’s largest beverage market (and cannabis market), Tinley represents an efficient, pure-play vehicle for investing in the growth of the burgeoning cannabis beverage sector

Working in collaboration with a California-based tequila formulator, Los Angeles-based Tinley Beverage Company (CSE: TNY) (OTCQX: TNYBF) has developed a line of ready-made, alcohol-free, cannabis-infused beverages that are made with authentic extracts, ethers, flavors and spices that are found in the world’s favorite cocktails and spirits (http://ibn.fm/azl7c). Doses range from 5mg THC per bottle for its single-serve, pre-mixed cocktails to over 40mg THC per bottle for its hard liquor-inspired products. These products enable consumers to enjoy familiar beverage formats in recreational settings, but with a mild tetrahydrocannabinol (THC) “high” instead of an alcohol effect.

Tinley President Rick Gillis was previously president of Young’s Market Company, a $3 billion beverage alcohol distributor based in California. Tinley’s team also includes past presidents, GMs and C-level executives from Cott (the third-largest beverage company globally after Coke and Pepsi), Coke, Dan Aykroyd Wines and Crystal Head Vodka.

Upon signing a partnership in Canada with the Hydropothecary Corporation (TSX: HEXO), Mark R. Hunter, CEO of Molson Coors (NYSE: TAP) (TSX: TPX.A) (TSX: TPX.B), a $5 billion global brewer, suggested that cannabis-infused beverages could grow to 20-30 percent of the overall cannabis industry. With Canada’s Bank of Montreal forecasting that the global cannabis industry will grow to $194 billion within seven years, this estimate suggests that the cannabis beverage category could grow to $38-58 billion during this time.

Tinley is uniquely positioned as a leading vehicle for public market investors to participate in this expected growth. It has a head start with beverages in market, an all-star team, an ideal location and, perhaps most importantly, a singular focus on beverages. This singular focus – without participation in cultivation, extraction, edibles, retail, hemp seed or non-cannabis drinks – effectively positions Tinley as an efficient, pure-play vehicle for investing in the growth of the rapidly-emerging cannabis beverage category.

Southern California is the U.S.’s largest conventional beverage market for a reason – year-round sunshine, 200+ million tourist visits annually, affluent cities and nearly 40 million people within an eight-hour shipping radius. These factors should also drive the success of the cannabis beverage industry in the state, particularly given California’s standing as the country’s largest cannabis market. With products already on the market in California, Tinley has a head start in terms of brand awareness, scaled production expertise and consumer marketing techniques – all of which it plans to leverage elsewhere in the U.S., as well as in Canada once drinks become legal later in 2019.

Cannabis investors are increasingly interested in shifting their portfolios to downstream cannabis products (e.g. branded edibles, capsules, topicals and drinks) and services (e.g. manufacturing, distribution and retail). However, it can be challenging for investors to pick individual product winners. Tinley solves this problem by giving its investors exposure to a highly diversified lineup of Tinley-branded products, as well as an increasing lineup of beverages that Tinley produces at its facilities on behalf of third-party co-packing clients. Its facility is capable of bottling for sodas, de-alcoholized wines and beers, fruit juices, coffees and other popular beverage categories, thereby giving Tinley’s investors exposure to a broad product lineup, as well as revenue from beverage infrastructure services.

“Cannabis beverages stand to become one of the fastest-growing categories within the cannabis industry, and these products are increasingly proving to be synergistic with beverage alcohol and other CPG (consumer packaged goods) products,” former alcohol distributor Young’s Market Company President Richard Gillis stated in a news release when he was named the president of Tinley’s California division in November 2018 (http://ibn.fm/cExeC).

For more information, visit the company’s website at www.DrinkTinley.com

• Supreme Cannabis Company pursuing new opportunities to build innovative cannabis businesses worldwide
• Its unique 7ACRES licensed producer subsidiary sets the company apart
• Supreme Cannabis is experiencing significant revenue growth

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) actively concentrates on its mission to grow sustainable cannabis businesses. Since 2014, the Toronto, Canada-based company has been at the center of the cannabis space, including forming 7ACRES as the first licensed producer focused on growing high-quality cannabis in high quantities. Supreme Cannabis’ wholly owned operating subsidiary and flagship brand, 7ACRES is committed to delivering on the company’s “craft quality, commercial scale” mantra.

Supreme Cannabis Company’s impressive growth also stems from its strong portfolio, powerful distribution partners and impressive industry agreements, including a one-year C$12 million supply agreement with Tilray Inc. to support medical cannabis patients (http://ibn.fm/X4bbe). Another industry agreement includes an exclusive consulting services agreement with Khalifa Kush Enterprises Canada ULC (an affiliate of Khalifa Kush Enterprises LLC), with an aim to develop and bring to market a line of premium cannabis products, including pre-rolls, extracts, capsules and cannabis oils, which Supreme Cannabis will sell under the KKE brand (http://ibn.fm/r8Jtu).

Regarding its portfolio, 7ACRES is positioned to become Canada’s foremost cultivator of consistently first-rate commercial cannabis. One of Canada’s first 40 federally licensed cannabis producers, 7ACRES operates a 440,000-square-foot facility in Kincardine, Ontario, and was federally licensed to begin production on March 11, 2016 (http://ibn.fm/Lc5Re).

Supreme Cannabis’ state-of-the-art greenhouse, technology and careful cultivation practices underwent development to enable 7ACRES to grow premier cannabis sustainably and at scale. In essence, 7ACRES merges the best practices in indoor cannabis cultivation with the strength of the sun. The result is indoor-quality buds with sun-grown characteristics. 7ACRES was recognized as ‘Brand of the Year’ at the 2018 Canadian Cannabis Awards presented by Lift & Company (http://ibn.fm/Dpk1F).

Pertaining to distribution, Supreme Cannabis has supply agreements in place throughout eight Canadian provinces, as well as a partnership with Medigrow Lesotho Limited targeting the export of medical cannabis oil for the international market. Moreover, Supreme Cannabis has partnerships with Canadian cannabis retailers, including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis and others, to further its distribution in the medical cannabis market (http://ibn.fm/R0GcG).

Supreme Cannabis Company is seeing its initiatives bear fruit in increased revenues. For Q2 2019, the company’s revenue was $7.72 million, a 359 percent increase over revenue of $1.68 million in Q2 2018. Furthermore, that figure represents a 50 percent increase from Q1 2019 revenues of $5.14 million (http://ibn.fm/v9mPB).

In a news release, Navdeep Dhaliwal, chief executive officer of Supreme Cannabis, noted, “We’re pleased with our second-quarter results, which show meaningful revenue growth quarter over quarter and continue to reflect our strong operational execution. Since Supreme received its license more than two years ago, we have been one of the fastest scaling licensed producers in Canada, demonstrated by one of the strongest first years of revenue in the sector.”

With a vision of being a worldwide cannabis leader, Supreme Cannabis Company continues to identify new opportunities to build unique cannabis businesses globally. The company estimates it can reach full production capacity in 2019, which would mean an increase from its present 17,500 kg to 50,000 kg annual production. For investors, Supreme Cannabis Company offers the potential for sustained growth in the dynamic cannabis sector.

For more information, visit the company’s website at www.Supreme.ca

• Icon Exploration Inc.’s vision is to be a leader in Canada’s medicinal and recreational cannabis markets
• Icon’s strategy is to acquire through a reverse merger with a vertically integrated cannabis company
• Acquisition would give Icon a 40,000-square-foot cultivation facility and an option on a 125,000-square-foot farm/extraction space

Icon Exploration Inc. (TSX.V: IEX.H) has set its sights on entering the Canadian cannabis industry, which Deloitte predicts will surpass $7 billion this year, including $4.4 billion in legalized recreational cannabis alone (http://ibn.fm/vEayT). To enter this market, Icon anticipates a reverse merger with cannabis company City View Green (“CVG”), which has already applied to Health Canada for an ACMPR license (http://ibn.fm/G33gt).

Icon Exploration is pursuing a strategy of vertical integration. The company plans to “use the burgeoning market as a platform to bring modernization to other verticals, specifically with regard to cannabis derivatives and extracts,” such as edibles, tinctures, capsules and oils (http://ibn.fm/tTY9K).

With the move, Icon would acquire CVG’s planned 40,000-square-foot growing facility in Brantford, Ontario. In addition, Icon would obtain 125,000 square feet of space that could be used for the production of cannabis vertical products, which could play a key role in the company’s marketing strategy.

“We’re entering the market at just the right time. We’re getting in at the second inning of a long ball game,” Icon Exploration CEO Rob Fia saod in an interview last year with Postmedia Content Works (http://ibn.fm/o8D2A). “There’s a lot of room to be a powerful entry into the space, and once the market sees what we’ve done here, it will be very exciting.”

Deloitte’s second report on Canada’s cannabis market, ‘A Society in Transition, an Industry Ready to Bloom’, projects that more than half — or $4.34 billion — of the estimated $7 billion in sales seen this year will come from legal recreational cannabis. Another $1.79 billion is forecast to come from medical cannabis, while the illegal market could ring up more than $1 billion in sales, per Deloitte.

For more information, visit the company’s website at www.IconExploration.net

• Cosmeceutical industry forecasts anticipate $73 billion market for cosmetic skin care products utilizing active chemical ingredients by 2023
• Therma Bright is using trademarked infrared head technologies to target skin viruses and establish a protective barrier for the human body’s largest organ
• Company is also exploring cannabidiol’s properties as augmenting agent for thermal technologies in fighting pain

Far from being mere tissue, skin is the human body’s largest and fastest-growing organ and a vital protection against harm to all of the body’s other organs and the systems that regulate their function (http://ibn.fm/4AO39), which provides an obvious reason for trying to keep skin healthy. Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) is focusing its business mission on the development of innovative technologies that strengthen and sustain the body’s outer layer and help people to live healthier lives as a result.

The key to Therma Bright’s vision of enhancing health and wellness is to employ trademarked infrared heat technology against agents that attack the skin, such as insect stings, bites and viruses. The company’s TherOZap technology is a first-generation medical device approved by the U.S. Food and Drug Administration (“FDA”) for the relief of the symptoms of skin pain, itch and inflammation, but Therma Bright has been working on a corollary product that may establish a barrier against stinging and biting insects to combat the Zika virus and other mosquito-borne diseases such as dengue.

Therma Bright is testing final prototypes of the technology against the Zika virus at a research laboratory in a process that’s expected to take several months (http://ibn.fm/KlXYA). Initial pre-clinical test results announced last year, when the company was named Jenex, indicated that Toronto, Canada’s Techna Institute had found TherOZap effective for the inactivation of live Zika virus in culture media and the inhibition of Zika virus infection into cultured cells in vitro, according to a company news release (http://ibn.fm/gSwaT).

Those findings led Robert A. Poggie, a regulatory consultant for the FDA, to declare, “Pre-clinical testing of the TherOZap technology indicates effectiveness in inhibiting Zika virus, which holds promise for the US FDA accepting marketing claims and associated data via 510(k) review,” according to the news release.

A second trademarked Therma Bright technology, InterceptCS, has also received some regulatory recognition for the treatment of cold sores by killing cells infected with the herpes simplex Type 1 virus. Based on a double-blind placebo study, InterceptCS is approved for the claim, “For prevention of cold sores when used within three hours of the onset of the prodrome” by Health Canada. The InterceptCS technology is not, however, approved by the United States’ FDA for any claim of clinical indication, clinical efficacy and/or cure or prevention of disease at this time.

InterceptCS delivers controlled topical heat with no risk of burning the skin as it targets the cold sore virus-infected cells. The company’s technologies are representative of a broader cosmeceutical industry that produces products with cosmetic applications of active potential chemical ingredients.

Industry forecasts anticipate a growing worldwide market for cosmeceuticals, with one prediction forecasting growth at a CAGR of 8.21 percent between 2017 and 2023, when the market is expected to reach about $73 billion (http://ibn.fm/q6Ew2).

Therma Bright is also turning to the positive word of mouth surrounding cannabidiol (“CBD”) for testing the cannabis plant-derived active ingredient in concert with the company’s thermal products as a means of enhancing pain relief therapies (http://ibn.fm/5mAes).

For more information, visit the company’s website at www.ThermaBright.com

• Immersed in competitive U.S. market, PLUS rose from 12th to number one
• PLUS benefits from the expertise of Michelin-star chefs, Ivy League chemists and others
• Company donates a portion of proceeds from limited edition products to the National Park Foundation and the Trevor Project

Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) recognized early that the strongest brands in the cannabis industry would emerge from California. California is the largest market in the world, expected to reach $5 billion in legal sales this year. The state also has a long history of medical legalization, making it the most competitive market available. The pressure and challenge of being immersed with the best in the business launched PLUS to the number one best-selling edible brand in California during Q3 2018 (http://ibn.fm/AFfte).

“Plus Products is a cannabis manufacturing product company, and our vision is to build the strongest cannabis brand,” Jake Heimark, CEO and co-founder of PLUS, stated in a Business Television segment (http://ibn.fm/nwIbp). “In the last year, PLUS moved from about 12th in edibles in California to being the number one edible company in what is the largest cannabis market in the world.”

PLUS’ products are exclusively available in California. The company’s cannabis-infused gummy candy is created to support a healthy, active lifestyle and sells in over 200 licensed dispensaries and delivery services.

The company utilizes the expertise of Michelin-star chefs, Ivy League chemists, food manufacturing experts, engineers, machinists, visionaries, creatives, strategists and others in executing its strategy. The goal is to create dosable and delicious products that provide a consistent experience.

PLUS rolls out limited-edition cannabis-infused gummies with the seasons. The current limited edition is Pink Lemonade Refresh, and a portion of the proceeds from this product will be donated to the National Parks Foundation. Last summer, the limited edition was a rainbow sorbet, with a portion of each purchase donated to the Trevor Project, a confidential suicide hotline for LGBT youth.

PLUS focuses on four consistent cannabis-infused gummies sold year-round and exclusively in California:

• Blackberry & Lemon RESTORE
• Sour Watermelon UPLIFT
• Pineapple & Coconut CBD RELIEF
• Sour Blueberry CREATE

Every PLUS product is made from scratch with carefully sourced high-quality extracts and kosher ingredients.

In addition to the company’s rise in the ranks, it was added to the OTCQB Venture Market under the symbol ‘PLPRF’ on January 23, 2019. The company will continue to trade on the Canadian Securities Exchange under the symbol ‘PLUS’.

“We are pleased to be approved to trade on the OTCQB platform and expect to access a greater range of U.S. institutional and retail investors, while at the same time providing U.S. investors access to our securities on a recognized U.S. securities trading platform,” Heimark said in a recent press release (http://ibn.fm/cJeik). “We have a strong U.S. investor base, and this will allow us to provide greater transparency to our current and future shareholders.”

For more information, visit the company’s website at www.PlusProducts.com

• Company recently announced submission of its application for common share listing on the Nasdaq Capital Market
• Uplisting will give the company broader access to international investors, Flowr executives believe
• Further steps are being undertaken to turn Flowr into a truly global company that benefits from serious competitive advantage over other cannabis producers

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF), a Canadian licensed producer of premium cannabis products, announced in February that it has submitted an application for its common shares to be listed on the Nasdaq Capital Market. The company has also filed a Form 40-F registration statement with the U.S. Securities and Exchange Commission (“SEC”), according to a news release (http://ibn.fm/KIXOc).

Various regulatory requirements need to be met for the Nasdaq listing to be finalized. The Canadian Flowr Corporation will need to go through the registration of its common shares with the SEC and an assessment by Nasdaq to determine if Flowr has satisfied its listing requirements.

Until the approval becomes effective, Flowr Corporation shares will continue to trade on the OTC under ticker symbol ‘FLWPF’. Once all regulatory requirements have been fulfilled, a trading date will be made public.

A Nasdaq listing is an important step toward broadening Flowr’s access to international investors, company co-CEO Vinay Tolia said in a news release. So far, the company has made massive progress executing its business plan since going public in 2018. Further steps are being undertaken to turn Flowr into a truly global company, Tolia underlined.

To date, the Canadian cannabis licensed producer has designed and built 17 cultivation facilities. All of them feature innovative technologies and solutions that ensure high yields and low production cost. These facts give Flowr a competitive advantage in a niche that’s quickly expanding.

In the next few years, the cannabis product market is anticipated to go through a number of important changes. A supply glut is anticipated in the Canadian cannabis sector, with supply set to potentially exceed demand by 2020, according to analyst projections (http://ibn.fm/dGxBe). As a result, producers who ensure high yields and cost efficiency will benefit from serious competitive advantage.

Flowr is already registering exceptional yield per square foot in its facilities. Due to its experience and focus on innovative cultivation practices, the company has reached a price point that other cannabis companies may be incapable of achieving.

The company is currently working on optimizing its yield even further. In 2019, Flowr expects to reach a production cost landmark of C$2.05 per gram.

In January 2019, Flowr announced a multilayer supply deal with Shoppers Drug Mart online store. Shoppers Drug Mart is Canada’s largest retail pharmacy chain. There are over 1,300 Shoppers Drug Mart locations across the country, and the partnership will give Shopper’s extensive patient network access to Flowr’s premium medicinal cannabis.

For more information, visit the company’s website at www.Flowr.ca

• Legislative changes have increased the popularity of cannabis products in the U.S. and Canada; as a result, consumers have started looking for high quality and premium-grade developments in the field
• Green Hygienics Holdings is investing in innovative cultivation practices that ensure both the quality and the yield of cannabis
• The company focuses on premium cannabis-derived products obtained via proprietary aeroponics cultivation technology that comes with record low production costs

As the legal cannabis sector expands, competition between companies in the field is also intensifying, with producers and distributors constantly looking for some competitive advantage in order to secure a solid market position. New technologies, especially in regard to cultivation processes, can provide this much sought-after advantage.

One company capitalizing on a proprietary cultivation technique is Green Hygienics Holdings Inc. (OTCQB: GRYN). The company is investing in innovative cultivation technologies that maximize yield and reduce the cost of production – two advantages that give Green Hygienics a unique position on a market that’s defined by a growing demand for premium-grade cannabis products.

Green Hygienics Holdings is quickly establishing itself as a leader in the advancement of science-driven cultivation systems. The company employs a unique aeroponics-based cultivation method through which nutrients are delivered to the exposed roots of the plant. Apart from increasing crop yields, this cultivation method is highly environmentally-friendly. According to Green Hygienics Holdings, aeroponics cultivation uses anywhere between 90 and 95 percent less water than standard agricultural practices. Pesticides and fungicides are also not required.

On top of being more sustainable, this cultivation technique reduces the cost of cannabis production, produces higher yields, ensures better quality and provides more control over the entire process.

As the cannabis market is still relatively young but constantly growing, competition is also intensifying considerably. According to experts, production efficiency and low costs are going to be the primary factors determining the success of cannabis producers in this high-competition environment.

Both of these goals can be accomplished through the adoption of innovative solutions like those used in the Green Hygienics Holdings cultivation methodology. The cost per unit for Green Hygienics Holdings’ production is less than $1. The industry standard for traditional cultivation is anywhere between $2 and $4 per unit.

On top of relying on innovative cultivation, Green Hygienics also invests in the technology that provides a greater degree of control over many aspects of the process.

Quality-controlled commercial cultivation equipment and software provide Green Hygienics with data that can be used to monitor and control the growth of cannabis. Cultivation problems are easy to identify this way, which results in the introduction of immediate measures to rectify the issue.

Green Hygienics expects these innovations to enable to meet its growth goals in 2019. The company intends to continue generating revenue from the cultivation and sale of premium-grade cannabis-derived products. Previously, Green Hygienics announced its intentions to develop and license additional intellectual property assets, make strategic acquisitions and develop globally-trusted consumer brands.

For more information, visit the company’s website at www.GreenHygienicsHoldings.com

• Sproutly Canada focusing on recreational cannabis beverage, edibles market as effective alternative to smoked weed
• Cannabis-infused beverage market expected to net revenues between $900 million and $4.4 billion by 2024
• Sproutly building on initial harvest success with planting in remaining Toronto facility flower rooms as it awaits license amendment, new market legalization

Sproutly Canada Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) is strengthening its cannabis beverage and edibles supply operations as Canada, where it is based, proceeds from legalizing recreational cannabis use for adults last year to legally licensing cannabis edibles and beverages later this year.

Canada’s efforts to establish policy structures for use of the green plant’s long-touted medicinal and relaxing properties, overturning decades of drug war directives, has given it a groundbreaking stature amid the increasingly fertile popular culture granting new acceptance to marijuana and hemp products.

Since listing on the OTC and Canadian exchanges last year, Sproutly Canada has added experienced executives, built its supply networks and increased its output capability in its drive to create the first natural, truly water-soluble cannabis solution that mimics the rapid onset and rapid wear-off effects of inhaled cannabis without the detrimental effects of smoking the product.

A February 13 news release noted additional recent developments in the company’s build-up strategy, including the first two successful harvests of its premium quality, small batch cannabis at its state-of-the-art production facility in Toronto and the migration of its ACMPR license to Canada’s Cannabis Act, which allows it to sell cannabis to other licensed producers (http://ibn.fm/sBISU).

“We are very happy with the results of our first two harvests, which produced highly efficient yields for an initial grow,” Sproutly President Bryan Semkuley stated in a news release. “This is a tremendous milestone for the company, as these harvests are the first step toward our production objectives. We are on track to meet our calendar 2019 production targets and expect multiple successful harvests as we continue to build on this initial success.”

The company is working to produce the same measure of success in the remainder of its 12 flowering rooms at the Toronto Herbal Remedies production facility as the company begins introducing plants in the other rooms this month, planting a new room each week as part of its strategy to maintain a perpetual harvest.

The company has received license amendments allowing it to use the entire THR facility for growing and cultivation operations, and its executives submitted another amendment request in November to allow it to produce cannabis oils through extraction and research operations.

Sproutly’s acquisition of Infusion Biosciences Canada Inc. granted it exclusive access to Infusion’s patent-pending APP Technology, which gently recovers 85 to 90 percent of the total bioactive cannabinoids in plants, including water-soluble cannabinoids and natural oils.

The company is analyzing the benefits of partnering with existing beverage brands, as well as launching its own portfolio of beverages, as it awaits legalization of that market.

“Sproutly has made significant progress towards building a world-class cannabis beverage and infused product company since going public in July of last year,” CEO and Director Keith Dolo stated in the news release.

Analysts at Deloitte peg the potential revenues for the cannabis-infused beverages market at somewhere between $900 million and $4.4 billion by 2024, depending on the percentage of the market that it captures (http://ibn.fm/im9JW). Sproutly’s products have the potential to set their own bar as part of a premium market.

For more information, visit the company’s website at www.Sproutly.ca